arrow
返回

Mathematical Model-Driven Deep Learning Enables Personalized Adaptive Therapy

delete2024-04-03
delete3
delete
OA
AI
K
Kit Gallagher *
M
Maximilian Strobl
D
Derek S. Park
F
Fabian C. Spoendlin
R
Robert A. Gatenby
P
Philip K. Maini
A
Alexander R.A. Anderson *
DOI:10.1158/0008-5472.CAN-23-2040delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
Standard-of-care treatment regimens have long been designed for maximal cell killing, yet these strategies often fail when applied to metastatic cancers due to the emergence of drug resistance. Adaptive treatment strategies have been developed as an alternative approach, dynamically adjusting treatment to suppress the growth of treatment-resistant populations and thereby delay, or even prevent, tumor progression. Promising clinical results in prostate cancer indicate the potential to optimize adaptive treatment protocols. Here, we applied deep reinforcement learning (DRL) to guide adaptive drug scheduling and demonstrated that these treatment schedules can outperform the current adaptive protocols in a mathematical model calibrated to prostate cancer dynamics, more than doubling the time to progression. The DRL strategies were robust to patient variability, including both tumor dynamics and clinical monitoring schedules. The DRL framework could produce interpretable, adaptive strategies based on a single tumor burden threshold, replicating and informing optimal treatment strategies. The DRL framework had no knowledge of the underlying mathematical tumor model, demonstrating the capability of DRL to help develop treatment strategies in novel or complex settings. Finally, a proposed five-step pathway, which combined mechanistic modeling with the DRL framework and integrated conventional tools to improve interpretability compared with traditional black-box DRL models, could allow translation of this approach to the clinic. Overall, the proposed framework generated personalized treatment schedules that consistently outperformed clinical standard-of-care protocols.
Keyword:
PROSTATE-CANCER
EVOLUTIONARY
CHEMOTHERAPY
RESISTANCE
SURVIVAL
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Cancer Research 封面图
Cancer Research
IF:
16.6
论文数:
10.9W
被引数:
11.9W

机构

H
h lee moffitt cancer center & research institute
学者数:
9.2K
论文数: 6.7K
被引数: 11
U
university of oxford
学者数:
9.8W
论文数: 8.6W
被引数: 137
引用论文

引用论文

err分享
err收藏
A theoretical analysis of tumour containment
err2021-04-12
err45
errOAAI
errViossat, Yannick; Noble, Robert
err分享
err收藏
Evolutionary dynamics of carcinogenesis and why targeted therapy does not work
err2012-06-14
err558
errOAAI
errGillies, Robert J.; Verduzco, Daniel; Gatenby, Robert A.
err分享
err收藏
err分享
err收藏
学者 查看更多内容